Previous Close | 1.1500 |
Open | 1.1400 |
Bid | 1.1200 x 900 |
Ask | 1.1700 x 1600 |
Day's Range | 1.1200 - 1.2000 |
52 Week Range | 0.7800 - 2.4800 |
Volume | |
Avg. Volume | 5,207,490 |
Market Cap | 241.035M |
Beta (5Y Monthly) | 0.93 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The analysts covering Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) delivered a dose of negativity to shareholders today...
Insights into Akebia Therapeutics' Performance and Strategic Developments
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript May 9, 2024 Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.08775, expectations were $-0.09. AKBA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Akebia’s […]